Zurcher Kantonalbank Zurich Cantonalbank Sells 15,455 Shares of Bruker Corporation $BRKR

Zurcher Kantonalbank Zurich Cantonalbank reduced its stake in Bruker Corporation (NASDAQ:BRKR) by 25.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 44,705 shares of the medical research company’s stock after selling 15,455 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Bruker were worth $2,106,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also recently made changes to their positions in the company. Allworth Financial LP boosted its position in shares of Bruker by 40.6% in the 3rd quarter. Allworth Financial LP now owns 890 shares of the medical research company’s stock worth $29,000 after purchasing an additional 257 shares in the last quarter. Spire Wealth Management boosted its position in shares of Bruker by 85.3% in the 3rd quarter. Spire Wealth Management now owns 1,445 shares of the medical research company’s stock worth $47,000 after purchasing an additional 665 shares in the last quarter. CWM LLC boosted its position in shares of Bruker by 49.8% in the 4th quarter. CWM LLC now owns 1,631 shares of the medical research company’s stock worth $77,000 after purchasing an additional 542 shares in the last quarter. Jones Financial Companies Lllp boosted its position in shares of Bruker by 79.7% in the 3rd quarter. Jones Financial Companies Lllp now owns 2,773 shares of the medical research company’s stock worth $86,000 after purchasing an additional 1,230 shares in the last quarter. Finally, EverSource Wealth Advisors LLC boosted its position in shares of Bruker by 51.5% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,770 shares of the medical research company’s stock worth $114,000 after purchasing an additional 942 shares in the last quarter. 79.52% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on BRKR shares. Weiss Ratings raised Bruker from a “sell (d)” rating to a “sell (d+)” rating in a research report on Friday. Citigroup decreased their price objective on shares of Bruker from $53.00 to $40.00 and set a “neutral” rating for the company in a report on Friday, February 13th. Barclays decreased their price objective on shares of Bruker from $50.00 to $45.00 and set an “overweight” rating for the company in a report on Tuesday, April 14th. TD Cowen upgraded shares of Bruker to a “hold” rating in a report on Monday, April 13th. Finally, Guggenheim decreased their price objective on shares of Bruker from $58.00 to $50.00 and set a “buy” rating for the company in a report on Monday, March 30th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have assigned a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, Bruker currently has a consensus rating of “Hold” and a consensus price target of $49.38.

Bruker Price Performance

Shares of NASDAQ BRKR opened at $36.53 on Tuesday. Bruker Corporation has a twelve month low of $28.53 and a twelve month high of $56.22. The firm has a market cap of $5.56 billion, a P/E ratio of -243.53, a PEG ratio of 2.19 and a beta of 1.20. The company has a 50 day moving average of $37.32 and a 200 day moving average of $41.98. The company has a quick ratio of 0.87, a current ratio of 1.73 and a debt-to-equity ratio of 0.75.

Bruker (NASDAQ:BRKR) last announced its quarterly earnings data on Thursday, February 12th. The medical research company reported $0.59 earnings per share for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.06). The firm had revenue of $977.20 million during the quarter, compared to analysts’ expectations of $964.61 million. Bruker had a positive return on equity of 13.56% and a negative net margin of 0.25%.Bruker’s revenue was down .2% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.76 earnings per share. Bruker has set its FY 2026 guidance at 2.100-2.150 EPS. As a group, research analysts expect that Bruker Corporation will post 2.12 EPS for the current fiscal year.

Bruker Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, April 7th. Shareholders of record on Monday, March 23rd were paid a dividend of $0.05 per share. The ex-dividend date was Monday, March 23rd. This represents a $0.20 dividend on an annualized basis and a yield of 0.5%. Bruker’s payout ratio is currently -133.33%.

Insiders Place Their Bets

In other Bruker news, VP Mark Munch sold 2,000 shares of the business’s stock in a transaction on Wednesday, April 15th. The shares were sold at an average price of $39.90, for a total transaction of $79,800.00. Following the completion of the sale, the vice president directly owned 128,443 shares in the company, valued at approximately $5,124,875.70. The trade was a 1.53% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 27.20% of the company’s stock.

About Bruker

Bruker Corporation, founded in 1960 by physicist Günther Laukien and headquartered in Billerica, Massachusetts, is a leading developer and manufacturer of high-performance scientific instruments and analytical solutions. The company designs systems that enable molecular and materials research across academic, governmental, and industrial laboratories.

Bruker’s product portfolio encompasses nuclear magnetic resonance (NMR) spectrometers for molecular structure and dynamics studies, mass spectrometry platforms for proteomics and metabolomics, X-ray diffraction and scattering instruments for crystallography and materials characterization, atomic force and scanning probe microscopes for nanoscale surface analysis, as well as preclinical imaging systems such as micro-CT and MRI scanners.

In addition to hardware, Bruker provides software suites, applications support, training services, and long-term maintenance agreements to ensure optimal instrument performance.